Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 High adoption rate of advanced technologies and presence of sophisticated healthcare infrastructure
3.2.1.2 Increase in prevalence of cardiovascular diseases
3.2.1.3 Rising geriatric population
3.2.1.4 Rise in prevalence of rheumatic valvular heart diseases
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with atrial fibrillation devices
3.2.2.2 Lack of awareness regarding enhanced medical technologies in developing countries
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Reimbursement scenario
3.7 Atrial fibrillation catheter ablation procedures at global and regional level, 2021 - 2023
3.7.1 Global
3.7.2 North America
3.7.3 Europe
3.7.4 Asia Pacific
3.7.5 Latin America
3.7.6 Middle East & Africa
3.8 Catheter ablation centres, by region, 2021 - 2023
3.9 Atrial fibrillation devices market, 2021 -2032 (Units)
3.9.1 Global
3.9.2 North America
3.9.3 Europe
3.9.4 Asia Pacific
3.9.5 Latin America
3.9.6 MEA
3.10 Pricing analysis
3.11 Gap analysis
3.12 Porter's analysis
3.13 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 EP ablation catheters
5.2.1 Radiofrequency (RF)
5.2.2 Laser
5.2.3 Cryoablation
5.2.4 Ultrasound
5.2.5 Microwave
5.2.6 Other EP ablation catheters
5.3 Cardiac monitors or implantable loop recorder
5.4 EP diagnostic catheters
5.4.1 Advanced mapping catheters
5.4.2 Steerable catheters
5.4.3 Fixed curve catheters
5.5 Mapping and recording systems
5.6 Access devices
5.7 Intracardiac echocardiography (ICE)
5.8 Left atrial appendage (LAA) closure devices
5.9 Other products
Chapter 6 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Hospitals
6.3 Cardiac centers
6.4 Ambulatory surgical centers
6.5 Other end-users
Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Netherlands
7.3.7 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Rest of Latin America
7.6 Middle East and Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.2 Acutus Medical, Inc.
8.3 AtriCure, Inc.
8.4 Biotronik
8.5 Boston Scientific Corporation
8.6 CardioFocus
8.7 CathRx Ltd.
8.8 Hansen Medical, Inc.
8.9 Imricor
8.10 Johnson and Johnson (Biosense Webster)
8.11 Medtronic plc
8.12 MicroPort Scientific Corporation
8.13 OSYPKA MEDICAL
8.14 Stryker Corporation
8.15 Synaptic Medical
